Systemic therapy with lenvatinib in advanced hepatocellular carcinoma: what to do in the case of a complete radiologic response?
Open Access
- 1 April 2023
- journal article
- letter
- Published by Romanian Society of Gastroenterology and Hepatology in Journal of Gastrointestinal and Liver Diseases
- Vol. 32 (1) , 118-119
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Troubleshooting of reinterventions after stent-by-stent placement for malignant hilar biliary obstruction (with videos)Hepatobiliary & Pancreatic Diseases International, 2022
- Deceased Donor Liver Transplantation After Radioembolization for Hepatocellular Carcinoma and Portal Vein Tumoral Thrombosis: A Pilot StudyLiver Transplantation, 2021
- Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trialThe Lancet Gastroenterology & Hepatology, 2021
- Cholestatic Liver Disease: Current Treatment Strategies and New Therapeutic AgentsDrugs, 2021
- Bezafibrate for the Treatment of Cholestatic Pruritus: Time for a Change in Management?Gastroenterology, 2021
- Targeted therapy for hepatocellular carcinomaSignal Transduction and Targeted Therapy, 2020
- Celiac Disease AutoimmunityArchivum Immunologiae et Therapiae Experimentalis, 2018
- Bilateral versus unilateral placement of metal stents for inoperable high-grade malignant hilar biliary strictures: a multicenter, prospective, randomized study (with video)Gastrointestinal Endoscopy, 2017
- Primary hepatic angiosarcomaEuropean Journal of Surgical Oncology, 2015
- HLA class II high-resolution genotyping in Greek children with celiac disease and impact on disease susceptibilityPediatric Research, 2012